BHC Stock Recent News
BHC LATEST HEADLINES
Bausch (BHC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Bausch (BHC) surpasses third-quarter earnings and sales estimates as most of the business units post growth.
Bausch Health Companies Inc. (NYSE:BHC ) Q3 2023 Earnings Conference Call November 2, 2023 8:00 AM ET Company Participants Lisa Wilson - Investor Relations Thomas Appio - Chief Executive Officer John Barresi - Interim Chief Financial Officer Conference Call Participants Jason Gerberry - Bank of America Securities Umer Raffat - Evercore ISI David Amsellem - Piper Sandler Douglas Miehm - RBC Capital Markets Les Sulewski - Truist Securities Operator Greetings. Welcome to the Bausch Health Third Quarter 2023 Earnings Call.
Contact lens maker Bausch + Lomb Corporation reported third-quarter earnings that surpassed Wall Street projections, even as the company posted an $84 million loss. On an adjusted basis, accounting for amortization and pretax expenses, the company earned 22 cents per share, beating the average analyst estimate of 18 cents per share.
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter 2023 financial results on Wednesday, Nov. 1, 2023. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of.
LAVAL, QC / ACCESSWIRE / October 12, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release its third-quarter financial results on Thursday, Nov. 2, 2023. Bausch Health will host a conference call and live webcast at 8:00 a.m.
Bausch (BHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Bausch Health stock fell on Tuesday on the news of its CFO unexpectedly leaving. Wednesday brought a bounce as investors viewed the sell-off as a buying opportunity.
Tom Vadaketh is leaving as Bausch's CFO after less than two years with the company. Vadaketh helped oversee financial improvement for Bausch.
Bausch Health Cos. Inc. BHC, -1.76% shares fell nearly 3% premarket on Tuesday after the company announced late Monday that chief financial officer Tom Vadaketh has resigned effective Oct. 13 to pursue another opportunity.